Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,019 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies.
Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, Suzuki N, Morimoto A, Nakahara T, Iwabuchi Y, Miura E, Yamamoto Y, Sano Y, Funaki K, Yamagata B, Ueda R, Yoshizaki T, Mashima K, Shibata M, Oyama M, Okada K, Kubota M, Okita H, Takao M, Jinzaki M, Nakahara J, Mimura M, Ito D. Tezuka T, et al. Among authors: okada k. Brain Commun. 2021 Aug 24;3(4):fcab190. doi: 10.1093/braincomms/fcab190. eCollection 2021. Brain Commun. 2021. PMID: 34632382 Free PMC article.
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis.
Oyama M, Okada K, Masuda M, Shimizu Y, Yokoyama K, Uzawa A, Kawaguchi N, Ikeguchi R, Hoshino Y, Hatano T, Ozawa Y, Nakahara J, Aizawa H, Kitagawa K, Hattori N, Kuwabara S, Murai H, Suzuki S. Oyama M, et al. Among authors: okada k. Ther Adv Neurol Disord. 2020 Mar 18;13:1756286420904207. doi: 10.1177/1756286420904207. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32215054 Free PMC article.
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.
Morimoto S, Takahashi S, Ito D, Daté Y, Okada K, Kato C, Nakamura S, Ozawa F, Chyi CM, Nishiyama A, Suzuki N, Fujimori K, Kondo T, Takao M, Hirai M, Kabe Y, Suematsu M, Jinzaki M, Aoki M, Fujiki Y, Sato Y, Suzuki N, Nakahara J; Pooled Resource Open-Access ALS Clinical Trials Consortium; Okano H. Morimoto S, et al. Among authors: okada k. Cell Stem Cell. 2023 Jun 1;30(6):766-780.e9. doi: 10.1016/j.stem.2023.04.017. Cell Stem Cell. 2023. PMID: 37267913 Free article. Clinical Trial.
Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice.
Lee SY, Shoji H, Shimozawa A, Aoyagi H, Sato Y, Tsumagari K, Terumitsu M, Motegi H, Okada K, Sekiguchi K, Kuromitsu J, Nakahara J, Miyakawa T, Ito D. Lee SY, et al. Among authors: okada k. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200234. doi: 10.1212/NXI.0000000000200234. Epub 2024 Apr 24. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38657185 Free PMC article.
6,019 results